Establishes a special registration for physicians to administer schedule I eligible investigational drugs under the Federal Right to Try law.

The Freedom to Heal Act of 2025 establishes a special registration under the Controlled Substances Act for physicians to administer schedule I eligible investigational drugs to eligible patients under the Federal Right to Try law. The Attorney General must issue an interim final rule within 240 days of enactment and a final rule within two years. The bill outlines requirements for physician applications, including evidence of compliance with the Federal Food, Drug, and Cosmetic Act, training credentials, and site descriptions.

Establishes a special registration for physicians to administer schedule I eligible investigational drugs under the Federal Right to Try law.

The Freedom to Heal Act of 2025 establishes a special registration under the Controlled Substances Act for physicians to administer schedule I eligible investigational drugs to eligible patients under the Federal Right to Try law. The Attorney General must issue an interim final rule within 240 days of enactment and a final rule within two years. The bill outlines requirements for physician applications, including evidence of compliance with the Federal Food, Drug, and Cosmetic Act, training credentials, and site descriptions.